Note 5 - Fair Value Measurements - Roll-forward of the Carrying Value of the Contingent Consideration (Details) - Contingent Consideration [Member] $ in Thousands |
9 Months Ended |
|---|---|
|
Sep. 30, 2016
USD ($)
| |
| Asuragen [Member] | |
| Beginning Balance | $ 4,628 |
| Payments | (450) |
| Accretion | 243 |
| Adjustments to Fair Value | (1,174) |
| Ending Balance | 3,247 |
| RedPath [Member] | |
| Beginning Balance | 13,921 |
| Payments | |
| Accretion | 732 |
| Adjustments to Fair Value | |
| Ending Balance | 14,653 |
| Beginning Balance | 18,549 |
| Payments | (450) |
| Accretion | 975 |
| Adjustments to Fair Value | (1,174) |
| Ending Balance | $ 17,900 |
| X | ||||||||||
- Definition Amount of accretion of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|